These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 35906939)

  • 41. Association between pulse width and health-related quality of life after electroconvulsive therapy in patients with unipolar or bipolar depression: an observational register-based study.
    Ernstsson O; Heintz E; Nordenskjöld A; Johnson JA; Korkmaz S; Zethraeus N
    Nord J Psychiatry; 2024 Feb; 78(2):137-145. PubMed ID: 38079191
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Changes in chronic rhinosinusitis symptoms differentially associate with improvement in general health-related quality of life.
    Speth MM; Hoehle LP; Phillips KM; Caradonna DS; Gray ST; Sedaghat AR
    Ann Allergy Asthma Immunol; 2018 Aug; 121(2):195-199. PubMed ID: 29860050
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Long-Term Cognitive and Psychological Functioning in Post-Electroconvulsive Therapy Patients.
    Miller ML; Luu H; Gaasedelen O; Hahn-Ketter AE; Elmore A; Dezhkam N; Bayless J; Moser DJ; Whiteside DM
    J ECT; 2019 Mar; 35(1):27-34. PubMed ID: 29727307
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Differential Psychometric Properties of EuroQoL 5-Dimension 5-Level and Short-Form 6-Dimension Utility Measures in Low Back Pain.
    Cheung PWH; Wong CKH; Cheung JPY
    Spine (Phila Pa 1976); 2019 Jun; 44(11):E679-E686. PubMed ID: 30475342
    [TBL] [Abstract][Full Text] [Related]  

  • 45. EuroQOL-5D-3L does not adequately map quality-of-life deterioration in severely affected patients with epilepsy.
    Willems LM; Knake S; Rosenow F; Reese JP; Conradi N; Strzelczyk A
    Epilepsy Behav; 2022 Feb; 127():108554. PubMed ID: 35063789
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Validity of the EQ-5D in assessing and valuing health status in patients with schizophrenic, schizotypal or delusional disorders.
    König HH; Roick C; Angermeyer MC
    Eur Psychiatry; 2007 Apr; 22(3):177-87. PubMed ID: 17142014
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Health-related quality of life in rheumatoid arthritis: Systematic review and meta-analysis of EuroQoL (EQ-5D) utility scores from Asia.
    Haridoss M; Bagepally BS; Natarajan M
    Int J Rheum Dis; 2021 Mar; 24(3):314-326. PubMed ID: 33486900
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Negative cognitive schema modification as mediator of symptom improvement after electroconvulsive therapy in major depressive disorder.
    Scheepens DS; van Waarde JA; Ten Doesschate F; Westra M; Kroes MCW; Schene AH; Schoevers RA; Denys D; Ruhé HG; van Wingen GA
    J Affect Disord; 2022 Aug; 310():156-161. PubMed ID: 35490877
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The Efficacy and Cognitive Effects of Acute Course Electroconvulsive Therapy Are Equal in Adolescents, Transitional Age Youth, and Young Adults.
    Luccarelli J; McCoy TH; Uchida M; Green A; Seiner SJ; Henry ME
    J Child Adolesc Psychopharmacol; 2021 Oct; 31(8):538-544. PubMed ID: 34619038
    [No Abstract]   [Full Text] [Related]  

  • 50. Changes in health-related quality of life of Chinese populations measured by the EQ-5D-3 L: a comparison of the 2008 and 2013 National Health Services Surveys.
    Yao Q; Liu C; Zhang Y; Xu L
    Health Qual Life Outcomes; 2019 Mar; 17(1):43. PubMed ID: 30866953
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Relief of expressed suicidality in schizophrenia after electroconvulsive therapy: A naturalistic cohort study.
    Tor PC; Bin Abdin E; Hadzi-Pavlovic D; Loo C
    Psychiatry Res; 2020 Feb; 284():112759. PubMed ID: 31927303
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Efficacy of electroconvulsive therapy in treatment-resistant schizophrenia: a prospective open trial.
    Tang WK; Ungvari GS
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 May; 27(3):373-9. PubMed ID: 12691772
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The clinical effectiveness and cost of repetitive transcranial magnetic stimulation versus electroconvulsive therapy in severe depression: a multicentre pragmatic randomised controlled trial and economic analysis.
    McLoughlin DM; Mogg A; Eranti S; Pluck G; Purvis R; Edwards D; Landau S; Brown R; Rabe-Heskith S; Howard R; Philpot M; Rothwell J; Romeo R; Knapp M
    Health Technol Assess; 2007 Jul; 11(24):1-54. PubMed ID: 17580003
    [TBL] [Abstract][Full Text] [Related]  

  • 54. EQ-5D health utilities: exploring ways to improve upon responsiveness in psoriasis.
    Pickard AS; Gooderham M; Hartz S; Nicolay C
    J Med Econ; 2017 Jan; 20(1):19-27. PubMed ID: 27471948
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ictal EEG fractal dimension in ECT predicts outcome at 2 weeks in schizophrenia.
    Abhishekh HA; Thirthalli J; Manjegowda A; Phutane VH; Muralidharan K; Gangadhar BN
    Psychiatry Res; 2013 Sep; 209(2):155-9. PubMed ID: 23261182
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Psychometric validation of the EuroQoL 5-dimension (EQ-5D) questionnaire in patients with spondyloarthritis.
    Tsang HHL; Cheung JPY; Wong CKH; Cheung PWH; Lau CS; Chung HY
    Arthritis Res Ther; 2019 Jan; 21(1):41. PubMed ID: 30700326
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Usefulness of the Montreal Cognitive Assessment (MoCA) to monitor cognitive impairments in depressed patients receiving electroconvulsive therapy.
    Moirand R; Galvao F; Lecompte M; Poulet E; Haesebaert F; Brunelin J
    Psychiatry Res; 2018 Jan; 259():476-481. PubMed ID: 29149717
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Estimation of minimal clinically important change of the Japanese version of EQ-5D in patients with chronic noncancer pain: a retrospective research using real-world data.
    Yoshizawa K; Kobayashi H; Fujie M; Ogawa Y; Yajima T; Kawai K
    Health Qual Life Outcomes; 2016 Mar; 14():35. PubMed ID: 26931101
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Importance of remission and residual somatic symptoms in health-related quality of life among outpatients with major depressive disorder: a cross-sectional study.
    Woo JM; Jeon HJ; Noh E; Kim HJ; Lee SW; Lee KK; Kim SH; Hong JP
    Health Qual Life Outcomes; 2014 Dec; 12():188. PubMed ID: 25519704
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Naturalistic comparative study of outcome and cognitive effects of unmodified electro-convulsive therapy in schizophrenia, mania and severe depression in Nigeria.
    Ikeji OC; Ohaeri JU; Osahon RO; Agidee RO
    East Afr Med J; 1999 Nov; 76(11):644-50. PubMed ID: 10734527
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.